Journal of Infection and Chemotherapy Citation Rate 2026

ISSN 1341-321X eISSN 1437-7780 Elsevier BV JP

Q3 Quartile

About Journal of Infection and Chemotherapy
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Journal of Infection and Chemotherapy (JIC) is a peer-reviewed academic journal covering Antibiotic Resistance in Bacteria and Antibiotics Pharmacokinetics and Efficacy, published by Elsevier BV in JP, catalogued under ISSN 1341-321X (e-ISSN 1437-7780). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.37 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$2650 USD).

Journal of Infection and Chemotherapy Citation Rate 2026 — In Context

Journal of Infection and Chemotherapy has a 2025 2-Year Citation Rate (OpenAlex) of 1.37, placing it in the Q3 quartile within the Antibiotic Resistance in Bacteria research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Journal of Infection and Chemotherapy operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Journal of Infection and Chemotherapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Journal of Infection and Chemotherapy against similar journals in the field, use our journal comparison tool.

Submission Tips for Journal of Infection and Chemotherapy
  • Budget $2650 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Journal of Infection … Compares
Citation Rate vs Field Avg
+34%
Field avg: 1.02
APC vs Field Avg
-4%
Field avg: $2752

Compared against 3 journals in the same research areas.

ISSN (Print) 1341-321X
ISSN (Online) 1437-7780
Publisher Elsevier BV
Country Japan
APC / Cost $2650 USD
In-depth profile & metrics

Journal of Infection and Chemotherapy is published by Elsevier BV and based in Japan. It runs on a subscription or hybrid model with an article-processing charge of USD 2650.

In our subject taxonomy, Journal of Infection and Chemotherapy is classified under Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus and Bacterial Identification and Susceptibility Testing.

Journal of Infection and Chemotherapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 1.371.

Research Areas
Links
Frequently Asked Questions about Journal of Infection and Chemotherapy

Journal of Infection and Chemotherapy does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.371 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Journal of Infection and Chemotherapy is not an open access journal.

The Article Processing Charge (APC) for Journal of Infection and Chemotherapy is $2650 USD.

Journal of Infection and Chemotherapy is published by Elsevier BV.

Journal of Infection and Chemotherapy shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Journal of Infection and Chemotherapy is 1341-321X. Its electronic ISSN (eISSN) is 1437-7780.

Journal of Infection and Chemotherapy sits in the Q3 quartile based on its latest impact factor of 1.37, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.371
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.371 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Journal of Infection and Chem… against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S141781860

Get weekly updates for Antibiotic Resistance in Bacteria journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google